🇺🇸 FDA
Patent

US 11351118

Methods for ameliorating infusion reactions

granted A61KA61K31/192A61K45/06

Quick answer

US patent 11351118 (Methods for ameliorating infusion reactions) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/192, A61K45/06, A61K47/10, A61K47/24